JMIR Public Health Surveill. 2018 Nov 01;4(4):e10847. doi: 10.2196/10847.
Quantification of HIV-1 RNA Among Men Who Have Sex With Men Using an At-Home Self-Collected Dried Blood Spot Specimen: Feasibility Study.
JMIR public health and surveillance
Sabina Hirshfield, Richard A Teran, Martin J Downing, Mary Ann Chiasson, Hong-Van Tieu, Laura Dize, Charlotte A Gaydos
Affiliations
Affiliations
- Research and Evaluation, Public Health Solutions, New York, NY, United States.
- Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States.
- Psychology Department, Lehman College, Bronx, NY, United States.
- Division of Infectious Diseases, Department of Medicine, Columbia University Medical Center, New York, NY, United States.
- Laboratory of Infectious Disease Prevention, New York Blood Center, New York, NY, United States.
- Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD, United States.
PMID: 30389648
PMCID: PMC6238105 DOI: 10.2196/10847
Abstract
BACKGROUND: Suboptimal antiretroviral therapy (ART) adherence and disengagement in care present significant public health challenges because of the increased probability of HIV transmission. In the United States, men who have sex with men (MSM) continue to be disproportionately affected by HIV, highlighting a critical need to engage high-risk MSM living with HIV who are not engaged or retained in care.
OBJECTIVE: The aim of the study was to assess the feasibility of at-home blood self-collection and laboratory quantification of HIV-1 RNA viral load (VL) to report laboratory-based VL outcomes and compare self-reported and laboratory-reported VL.
METHODS: Between 2016 and 2017, 766 US HIV-positive MSM enrolled in a Web-based behavioral intervention were invited to participate in an at-home dried blood spot (DBS) collection study using HemaSpot-HF kits (Spot On Sciences, Inc, Austin, TX) for laboratory-quantified VL.
RESULTS: Of those invited to participate, 72.3% (554/766) enrolled in the DBS study. Most (79.2%, 439/554) men enrolled reported attempting to collect their blood, 75.5% (418/554) of participants mailed a DBS specimen to the research laboratory, and 60.8% (337/554) had an adequate blood sample for VL testing. Of the 337 specimens tested for VL by the laboratory, 52.5% (177/337) had detectable VL (median: 3508 copies/mL; range: 851-1,202,265 copies/mL). Most men (83.9%, 135/161) who returned a DBS specimen with laboratory-quantified detectable VL self-reported an undetectable VL during their last clinical visit.
CONCLUSIONS: Home collection of DBS samples from HIV-positive MSM is feasible and has the potential to support clinical VL monitoring. Discrepant laboratory HIV-1 RNA values and self-reported VL indicate a need to address perceived VL status, especially in the era of treatment as prevention. Most participants were willing to use an at-home DBS kit in the future, signaling an opportunity to engage high-risk MSM in long-term HIV care activities.
©Sabina Hirshfield, Richard A Teran, Martin J Downing Jr, Mary Ann Chiasson, Hong-Van Tieu, Laura Dize, Charlotte A Gaydos. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 01.11.2018.
Keywords: HIV-1; dried blood spot testing; men who have sex with men; viral load
References
- J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):126-133 - PubMed
- J Clin Microbiol. 2012 Mar;50(3):569-72 - PubMed
- AIDS Behav. 2018 Jul;22(7):2360-2367 - PubMed
- JMIR Res Protoc. 2016 Jun 17;5(2):e125 - PubMed
- AIDS Res Ther. 2016 Mar 22;13:16 - PubMed
- Arch Med Res. 2005 Jul-Aug;36(4):382-6 - PubMed
- J Clin Microbiol. 2014 May;52(5):1343-51 - PubMed
- J Clin Microbiol. 1997 Nov;35(11):2795-801 - PubMed
- JMIR Public Health Surveill. 2017 Feb 03;3(1):e8 - PubMed
- Indian J Med Res. 2012 Dec;136(6):956-62 - PubMed
- MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):969-974 - PubMed
- J Infect Dis. 2007 Dec 15;196(12):1773-8 - PubMed
- J Int Assoc Physicians AIDS Care (Chic). 2011 Nov-Dec;10(6):357-64 - PubMed
- Clin Infect Dis. 2009 Sep 15;49(6):976-81 - PubMed
- J Theor Biol. 2015 Apr 21;371:79-89 - PubMed
- AIDS Behav. 2016 Nov;20(11):2700-2708 - PubMed
- J Nutr. 2001 May;131(5):1631S-6S - PubMed
- J Clin Microbiol. 2018 Sep 25;56(10):null - PubMed
- J Clin Microbiol. 2009 Apr;47(4):1031-6 - PubMed
- Demography. 2007 Nov;44(4):899-925 - PubMed
- N Engl J Med. 2011 Aug 11;365(6):493-505 - PubMed
- Lancet HIV. 2017 Nov;4(11):e475 - PubMed
- JAMA. 2016 Jul 12;316(2):171-81 - PubMed
- J Clin Virol. 2010 Feb;47(2):120-5 - PubMed
- J Int Assoc Provid AIDS Care. 2016 Nov;15(6):463-469 - PubMed
- J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):e142-e144 - PubMed
- AIDS. 2017 May 15;31(8):1191-1193 - PubMed
- Antiviral Res. 2012 Mar;93(3):309-21 - PubMed
- Clin Infect Dis. 2012 Apr;54(8):1187-95 - PubMed
- Clin Chem. 2016 Mar;62(3):423-5 - PubMed
- PLoS One. 2017 Oct 20;12(10):e0186722 - PubMed
- Arch Sex Behav. 2015 Oct;44(7):1969-78 - PubMed
- J Sex Res. 2014;51(4):390-409 - PubMed
- Clin Microbiol Infect. 2009 Jan;15(1):93-7 - PubMed
- Sex Transm Dis. 2006 Sep;33(9):576-84 - PubMed
- J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e57-60 - PubMed
- J Clin Pathol. 1999 Sep;52(9):633-9 - PubMed
- BMC Res Notes. 2012 Aug 15;5:440 - PubMed
- AIDS. 2000 Aug 18;14(12):1819-28 - PubMed
- Springerplus. 2014 Feb 24;3:109 - PubMed
- J Acquir Immune Defic Syndr. 2016 Aug 15;72(5):579-84 - PubMed
- J Med Internet Res. 2013 Nov 14;15(11):e254 - PubMed
- Sex Transm Dis. 2006 Jul;33(7):451-7 - PubMed
Publication Types
Grant support